Published in World J Gastroenterol on June 14, 2015
The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer. Oncotarget (2016) 0.79
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique? J Transl Med (2015) 0.77
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World J Gastroenterol (2016) 0.76
Role of contrast-enhanced harmonic endoscopic ultrasound in submucosal tumors. Endosc Ultrasound (2016) 0.75
Safety of targeting tumor endothelial cell antigens. J Transl Med (2016) 0.75
High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study. Ecancermedicalscience (2017) 0.75
Botulinum toxin A improves adipose tissue engraftment by promoting cell proliferation, adipogenesis and angiogenesis. Int J Mol Med (2017) 0.75
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging. Gastric Cancer (2016) 0.75
Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol (2002) 20.87
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Tumor angiogenesis. N Engl J Med (2008) 11.30
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med (2006) 9.14
Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol (2006) 7.90
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol (2011) 4.19
Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol (2006) 4.14
Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer (2011) 3.55
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol (2006) 3.12
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol (2007) 2.82
Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res (2008) 2.75
Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res (2004) 2.67
CD105 is important for angiogenesis: evidence and potential applications. FASEB J (2003) 2.50
Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology (2005) 1.89
Histopathology of gastrointestinal stromal tumor. J Surg Oncol (2011) 1.61
The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta (2009) 1.61
Gastrointestinal stromal tumours: an update. Histopathology (2006) 1.50
Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol (2005) 1.41
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol (2004) 1.39
Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors. J Biol Chem (2006) 1.34
CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci (2003) 1.30
Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep (2003) 1.21
Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology (2003) 1.12
Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol (2008) 1.02
Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res (2007) 0.99
Different sites and prognoses of gastrointestinal stromal tumors of the stomach: report of 187 cases. World J Surg (2010) 0.98
Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. World J Gastroenterol (2013) 0.95
Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol (2011) 0.94
Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol (2007) 0.93
Prognostic significance of angiogenesis in gastrointestinal stromal tumor. Mod Pathol (2007) 0.92
The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis. Cancer Res (2013) 0.91
Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer (2000) 0.88
Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. Ir J Med Sci (2009) 0.87
Predicting recurrence-free survival after surgery for GIST. Lancet Oncol (2009) 0.87
Gastrointestinal stromal tumours--an update for histopathologists. Histopathology (2011) 0.86
Real-time tracking of parameters of lung mechanics: emphasis on algorithm tuning. J Biomed Eng (1990) 0.85
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res (2008) 0.85
ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours. J Cell Mol Med (2012) 0.81
Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior. Hepatogastroenterology (2009) 0.80
The importance of tumor angiogenesis: the evidence continues to grow. Am J Clin Pathol (2004) 0.80
Free and open-source software application for the evaluation of coronary computed tomography angiography images. Arq Bras Cardiol (2012) 0.78
Altered angiogenesis gene expression in gastrointestinal stromal tumors: potential use in diagnosis, outcome prediction, and treatment. Neoplasma (2012) 0.77